AGP Executive Report
Last update: 10 hours agoVisa Policy & Public Health Travel Risk: 11 EU countries are urging the European Commission to tighten visa rules for Russian citizens, citing rising tourist permits and fears that loopholes let more visitors reach Europe despite the war in Ukraine. Local Charity & Bereavement Care: Two men are cycling along the Rhine route through Switzerland, Liechtenstein, Austria, Germany, France and the Netherlands to raise funds for a dedicated baby-loss bereavement suite at Southmead Hospital. Cancer Treatment Access: The European Commission approved Bristol Myers Squibb’s Opdivo (nivolumab) plus AVD as the first immunotherapy-based regimen in the EU for newly diagnosed advanced classical Hodgkin lymphoma in adults and adolescents (12+). Pet Health Tech in the Region: Fi expanded AI-powered GPS pet wearables and connectivity to 38 countries, including coverage for Switzerland and Liechtenstein, aiming to help owners track health and behavior while traveling. Travel Costs & Healthcare Coverage: UK guidance highlights that travellers without a GHIC may miss state-provided medical treatment abroad, urging people to apply before travel (and still keep travel insurance). Medication Innovation: CinnaGen received EU approval for its osteoporosis drug teriparatide (Zandoriah), marking a first for an Iranian pharma company.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
